v3.26.1
Consolidated Statements of Cash Flows
$ in Millions, $ in Millions
12 Months Ended
Mar. 31, 2026
USD ($)
Mar. 31, 2025
USD ($)
Mar. 31, 2024
USD ($)
Cash Flows From Operating Activities      
Net income $ 104.0 $ 424.0 $ 510.2
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 493.5 216.2 185.0
Lease expense 41.8 32.9 26.9
Deferred income taxes (17.9) 62.1 34.6
Share-based compensation 38.0 23.0 28.2
Asbestos adjustments 51.8 137.6 151.7
Gain on sale of land (26.2) 0.0 (2.0)
Non-cash restructuring expenses 23.5 38.2 20.1
Non-cash interest expense 8.8 2.0 1.9
Non-cash charge related to step up of inventory 47.9 0.0 0.0
Other, net 41.5 19.1 29.7
Changes in operating assets and liabilities:      
Accounts and other receivables (15.6) (28.9) (19.7)
Inventories (48.5) (15.7) 3.4
Operating lease assets and liabilities, net (47.3) (34.0) (28.0)
Prepaid expenses and other assets (1.2) (40.6) (21.5)
Insurance receivable - Asbestos 3.8 3.9 5.6
Accounts payable and accrued liabilities 30.2 18.3 47.4
Claims and handling costs paid - Asbestos (107.0) (114.4) (116.0)
Income taxes payable 2.2 (2.7) (4.9)
Other accrued liabilities and interest (33.5) 61.8 61.6
Net cash provided by operating activities 589.8 802.8 914.2
Cash Flows From Investing Activities      
Purchases of property, plant and equipment (383.9) (422.2) (449.3)
Proceeds from sale of property, plant and equipment 108.2 0.4 4.2
Capitalized interest (6.1) (21.0) (19.5)
Cash consideration for The AZEK Company acquisition, net of cash acquired (3,919.8) 0.0 0.0
Purchase of restricted investments - Asbestos (190.1) (183.1) (144.2)
Proceeds from restricted investments - Asbestos 183.2 179.2 138.3
Net cash used in investing activities (4,208.5) (446.7) (470.5)
Cash Flows From Financing Activities      
Proceeds from term loans 2,500.0 0.0 300.0
Proceeds from senior secured notes 1,700.0 0.0 0.0
Proceeds from revolving credit facilities 130.0 0.0 95.0
Repayments of term loans (323.4) (7.5) (1.9)
Repayments of revolving credit facilities (130.0) 0.0 (325.0)
Repayment of senior unsecured notes (465.2) 0.0 0.0
Debt issuance costs paid (41.6) 0.0 (1.2)
Proceeds from issuance of shares 0.0 0.0 0.4
Proceeds from exercise of vested stock options 1.7 0.0 0.0
Share issuance costs due to AZEK acquisition (2.1) 0.0 0.0
Repayment of finance lease obligations (4.8) (1.2) (1.1)
Shares repurchased 0.0 (149.9) (271.4)
Shares issued, net of cash paid for shares withheld for taxes (13.7) (7.3) (4.9)
Net cash provided by (used in) financing activities 3,350.9 (165.9) (210.1)
Effects of exchange rate changes on cash and cash equivalents, restricted cash and restricted cash - Asbestos 6.6 (0.4) (3.4)
Net (decrease) increase in cash and cash equivalents, restricted cash and restricted cash - Asbestos (261.2) 189.8 230.2
Cash and cash equivalents, restricted cash and restricted cash - Asbestos at beginning of period 605.6 415.8 185.6
Cash and cash equivalents, restricted cash and restricted cash - Asbestos at end of period 344.4 605.6 415.8
Non-Cash Investing and Financing Activities      
Capital expenditures incurred but not yet paid 50.2 41.3 75.0
Non-cash ROU assets obtained in exchange for new lease liabilities 58.5 33.6 22.4
Non-cash consideration for AZEK acquisition 4,143.6 0.0 0.0
Supplemental Disclosure of Cash Flow Activities      
Cash paid for interest 207.8 63.6 41.8
Cash payment for income taxes, net 85.1 128.1 183.1
Cash paid to AICF $ 125.4 $ 99.2 $ 91.8